Trials / Completed
CompletedNCT05529030
COVID-19 Booster Readiness Survey
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 12,036 (actual)
- Sponsor
- Geisinger Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this administrative survey is to inform health system logistics by assessing the attitudes towards towards the bivalent COVID-19 boosters held by healthcare workers (HCWs) at a large, rural health system. It will also test, prospectively, the effect on interest in the bivalent COVID-19 booster of different framing approaches in a survey question sent to employees of a large, rural health system.
Detailed description
The Food and Drug Administration has authorized two bivalent COVID-19 boosters with the expectation that the Centers for Disease Control will soon recommend them. The researchers plan to survey the HCWs at a large, rural health system on their attitudes on the bivalent booster. This survey will gather data on HCWs' interest in a bivalent booster, reasons for hesitancy, risk perception about COVID-19 infection and its complications, and prior COVID-19 infection and vaccination. Respondents will also be randomly assigned to see different versions of the question asking if they are interested in a bivalent booster with different framing approaches, such as protection of the self or protection of patients (for patient-facing employees). Information on prior vaccination and perceptions of risk will also be gathered and used as covariates in the analysis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Salience of Omicron variant | The message mentions the Omicron variant, which can be a fear appeal or make salient the reason for the new booster |
| BEHAVIORAL | Self-protection message | The message makes a reference to protecting one's self |
| BEHAVIORAL | Other-protection message | The message makes a reference to protecting others (patients) |
Timeline
- Start date
- 2022-09-01
- Primary completion
- 2022-09-15
- Completion
- 2022-09-15
- First posted
- 2022-09-06
- Last updated
- 2022-09-30
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05529030. Inclusion in this directory is not an endorsement.